{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:09:22Z","timestamp":1790885362975,"version":"4.1.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2018,11,1]]},"DOI":"10.1001\/jamaneurol.2018.3139","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T15:12:57Z","timestamp":1540566777000},"page":"1347","source":"Crossref","is-referenced-by-count":90,"title":["Association of Apolipoprotein E \u03b54 With Transactive Response DNA-Binding Protein 43"],"prefix":"10.1001","volume":"75","author":[{"given":"Alexandra M.","family":"Wennberg","sequence":"first","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirubol","family":"Tosakulwong","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy G.","family":"Lesnick","sequence":"additional","affiliation":[{"name":"Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa E.","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Whitwell","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Liesinger","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Petrucelli","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley F.","family":"Boeve","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Parisi","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine and Pathology, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Knopman","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C.","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis W.","family":"Dickson","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Mayo Clinic, Jacksonville, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith A.","family":"Josephs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5054","key":"noi180071r1","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: the amyloid cascade hypothesis.","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"issue":"6","key":"noi180071r2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1086\/420978","article-title":"Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.","volume":"74","author":"Buratti","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"5","key":"noi180071r3","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1002\/(ISSN)1531-8249","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease.","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann Neurol"},{"issue":"5","key":"noi180071r4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ana.v78.5","article-title":"TAR DNA-binding protein 43 and pathological subtype of Alzheimer\u2019s disease impact clinical features.","volume":"78","author":"Josephs","year":"2015","journal-title":"Ann Neurol"},{"issue":"11","key":"noi180071r5","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia.","volume":"139","author":"James","year":"2016","journal-title":"Brain"},{"issue":"5","key":"noi180071r6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1001\/jamaneurol.2013.1957","article-title":"Neuropathologic basis of age-associated brain atrophy.","volume":"70","author":"Erten-Lyons","year":"2013","journal-title":"JAMA Neurol"},{"issue":"4","key":"noi180071r7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1212\/01.WNL.0000079053.77227.14","article-title":"Changes in premorbid brain volume predict Alzheimer\u2019s disease pathology.","volume":"61","author":"Silbert","year":"2003","journal-title":"Neurology"},{"issue":"6","key":"noi180071r8","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00401-014-1269-z","article-title":"TDP-43 is a key player in the clinical features associated with Alzheimer\u2019s disease.","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"4","key":"noi180071r9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00401-016-1537-1","article-title":"Updated TDP-43 in Alzheimer\u2019s disease staging scheme.","volume":"131","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"3","key":"noi180071r10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s00401-013-1211-9","article-title":"Staging TDP-43 pathology in Alzheimer\u2019s disease.","volume":"127","author":"Josephs","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"11","key":"noi180071r11","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S1474-4422(17)30284-3","article-title":"Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer\u2019s disease: a longitudinal retrospective study.","volume":"16","author":"Josephs","year":"2017","journal-title":"Lancet Neurol"},{"issue":"5","key":"noi180071r12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"noi180071r13","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S1474-4422(18)30251-5","article-title":"Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE e4 haplotype status: a community-based cohort study.","volume":"17","author":"Yang","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"noi180071r14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics.","volume":"30","author":"Roberts","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"1","key":"noi180071r15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach.","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"5","key":"noi180071r16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s00401-015-1390-7","article-title":"PART is part of Alzheimer disease.","volume":"129","author":"Duyckaerts","year":"2015","journal-title":"Acta Neuropathol"},{"issue":"2","key":"noi180071r17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0165-0270(94)90168-6","article-title":"Single-day apolipoprotein E genotyping.","volume":"53","author":"Crook","year":"1994","journal-title":"J Neurosci Methods"},{"issue":"10","key":"noi180071r18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1001\/archneur.61.10.1579","article-title":"Apolipoprotein E epsilon 4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration.","volume":"61","author":"Josephs","year":"2004","journal-title":"Arch Neurol"},{"issue":"4","key":"noi180071r19","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"issue":"4","key":"noi180071r20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes.","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"3","key":"noi180071r21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/BF00293396","article-title":"Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.","volume":"88","author":"Dickson","year":"1994","journal-title":"Acta Neuropathol"},{"issue":"3","key":"noi180071r22","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00401-014-1302-2","article-title":"Differential clinicopathologic and genetic features of late-onset amnestic dementias.","volume":"128","author":"Murray","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"18","key":"noi180071r23","doi-asserted-by":"publisher","first-page":"7607","DOI":"10.1073\/pnas.0900688106","article-title":"Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity.","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"noi180071r24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00401-008-0400-4","article-title":"Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer disease.","volume":"116","author":"Hu","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"2","key":"noi180071r25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan: an R package for structural equation modeling.","volume":"48","author":"Rosseel","year":"2012","journal-title":"J Stat Softw"},{"issue":"11","key":"noi180071r27","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","article-title":"Cognitive reserve in ageing and Alzheimer\u2019s disease.","volume":"11","author":"Stern","year":"2012","journal-title":"Lancet Neurol"},{"issue":"6","key":"noi180071r28","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1073\/pnas.0812697106","article-title":"Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer\u2019s disease and frontotemporal dementia.","volume":"106","author":"Agosta","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"noi180071r29","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","article-title":"Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated.","volume":"141","author":"Robinson","year":"2018","journal-title":"Brain"},{"issue":"5","key":"noi180071r30","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","article-title":"ApoE4 accelerates early seeding of amyloid pathology.","volume":"96","author":"Liu","year":"2017","journal-title":"Neuron"},{"issue":"2","key":"noi180071r31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy.","volume":"9","author":"Liu","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"19","key":"noi180071r32","doi-asserted-by":"publisher","first-page":"E1807","DOI":"10.1073\/pnas.1220484110","article-title":"ApoE influences amyloid-\u00df (A\u00df) clearance despite minimal APOE\/A\u00df association in physiological conditions.","volume":"110","author":"Verghese","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5123","key":"noi180071r33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families.","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"issue":"7673","key":"noi180071r34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nature24016","article-title":"ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.","volume":"549","author":"Shi","year":"2017","journal-title":"Nature"},{"key":"noi180071r26","unstructured":"Muth\u00e9nLK, Muth\u00e9nBO. Mplus user's guide. Los Angeles, CA: Muth\u00e9n & Muth\u00e9n; 1998-2017. https:\/\/www.statmodel.com\/download\/usersguide\/MplusUserGuideVer_8.pdf. Accessed February 1, 2018."}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2709106","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T11:00:38Z","timestamp":1542020438000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.3139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.3139","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11,1]]}}}